| scholarly article | Q13442814 |
| P50 | author | Sakineh Kazemi Noureini | Q56544559 |
| P2093 | author name string | Michael Wink | |
| Leili Fatemi | |||
| P2860 | cites work | Breast cancer survival is associated with telomere length in peripheral blood cells | Q51702224 |
| Chelidonine isolated from ethanolic extract of Chelidonium majus promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT signalling pathways. | Q53145282 | ||
| Telomere length dynamics in telomerase-positive immortal human cell populations | Q53435983 | ||
| Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity | Q73586375 | ||
| Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development | Q73670399 | ||
| Telomere length measurement by a novel monochrome multiplex quantitative PCR method | Q37108473 | ||
| Telomere and telomerase as targets for cancer therapy | Q37468610 | ||
| Telomerase: Structure, functions, and activity regulation | Q37854760 | ||
| Telomerase as a "stemness" enzyme | Q38211826 | ||
| Selectivity of major isoquinoline alkaloids from Chelidonium majus towards telomeric G-quadruplex: A study using a transition-FRET (t-FRET) assay | Q38288204 | ||
| The Interference of Selected Cytotoxic Alkaloids with the Cytoskeleton: An Insight into Their Modes of Action | Q38758021 | ||
| Structure and function of telomeres | Q38763424 | ||
| Telomerase and telomere biology in hematological diseases: A new therapeutic target | Q39135191 | ||
| Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine | Q39816965 | ||
| Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells | Q40047153 | ||
| Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or an | Q40375807 | ||
| Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment | Q40412924 | ||
| Telomere structure and function | Q40428297 | ||
| An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity | Q40825989 | ||
| Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts | Q41006486 | ||
| Structure and function of telomerase | Q41066960 | ||
| Pharmacological activities of Chelidonium majus L. (Papaveraceae). | Q41164899 | ||
| Larvicidal activity and insecticidal mechanism of Chelidonium majus on Lymantria dispar | Q50138569 | ||
| hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization | Q24310670 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies | Q26744271 | ||
| Telomere length regulation | Q28290143 | ||
| Dynamics of protein binding to telomeres in living cells: implications for telomere structure and function | Q30762674 | ||
| Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain | Q31158943 | ||
| The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways | Q32043480 | ||
| Quantitative theory of telomere length regulation and cellular senescence | Q33777886 | ||
| Alternative splicing regulation of telomerase: a new paradigm? | Q34310398 | ||
| Telomerase regulation: not just flipping the switch | Q34493169 | ||
| Longer Telomere Length in Peripheral White Blood Cells Is Associated with Risk of Lung Cancer and the rs2736100 (CLPTM1L-TERT) Polymorphism in a Prospective Cohort Study among Women in China | Q34650906 | ||
| Telomere maintenance and cancer -- look, no telomerase. | Q34988280 | ||
| Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment | Q35003665 | ||
| High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis. | Q35096589 | ||
| Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome | Q35558080 | ||
| Telomeres: cancer to human aging | Q36528826 | ||
| Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines | Q36556649 | ||
| Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study | Q36854065 | ||
| Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. | Q36885740 | ||
| Role of telomeres and telomerase in genomic instability, senescence and cancer | Q36927502 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0204901 | |
| P577 | publication date | 2018-10-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine | |
| P478 | volume | 13 |
| Q89976569 | Effective Inhibition of Candidiasis Using an Eco-Friendly Leaf Extract of Calotropis-gigantean-Mediated Silver Nanoparticles | cites work | P2860 |
Search more.